Ceribell Neurology Review Software
Automatic Event Detection Software For Full-Montage Electroencephalograph. 510(k) K260998, from Ceribell, Inc. (Sunnyvale, CA). Product code OMB, class 2.
As of Nov 19, 2026, K260998 is an FDA 510(k) held by Ceribell, Inc., substantially equivalent on Jun 24, 2026 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
The Ceribell Neurology Review Software is intended for the review, monitoring and analysis of EEG recordings made by electroencephalogram (EEG) devices using scalp electrodes and to aid neurologists in the assessment of EEG. This device is intended to be used by qualified clinical practitioners who will exercise professional judgment in using the information.
- encevis (2.1)K240993 · Ait Austrian Institute of Technology GmbH · Sep 27, 2024
- autoSCORE (V 2.0.0)K243743 · Holberg Eeg AS · Apr 9, 2025
- Ceribell Infant Seizure Detection SoftwareK252070 · Ceribell, Inc. · Nov 21, 2025
- Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))K252160 · Persyst Development, LLC · Oct 31, 2025
- Ceribell Seizure Detection SoftwareK241589 · Ceribell, Inc. · Apr 9, 2025
- autoSCORE (V 2.0.0)K243743 · Holberg Eeg AS · Apr 9, 2025
- Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))K242446 · Persyst Development Corporation · Jan 22, 2025
- NeuroMatchK241390 · LVIS Corporation · Nov 26, 2024
- REMI-AI Rapid Detection Module (REMI-AI RDM)K240408 · Epitel, Inc. · Oct 17, 2024
- encevis (2.1)K240993 · Ait Austrian Institute of Technology GmbH · Sep 27, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 26, 2026
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1400
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files